|
|
Blood, 1 August 2005, Vol. 106, No. 3, pp. 1113-1122.
Prepublished online as a Blood First Edition Paper on April 26, 2005; DOI 10.1182/blood-2005-02-0509.
 Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
Andreas Beilhack,
Stephan Schulz,
Jeanette Baker,
Georg F. Beilhack,
Courtney B. Wieland,
Edward I. Herman,
Enosh M. Baker,
Yu-An Cao,
Christopher H. Contag, and
Robert S. Negrin
From the Departments of Medicine and Pediatrics, Stanford University, Stanford, CA.
Graft-versus-host disease (GVHD) is a major obstacle in allogeneic hematopoietic cell transplantation. Given the dynamic changes in immune cell subsets and tissue organization, which occur in GVHD, localization and timing of critical immunological events in vivo may reveal basic pathogenic mechanisms. To this end, we transplanted luciferase-labeled allogeneic splenocytes and monitored tissue distribution by in vivo bioluminescence imaging. High-resolution analyses showed initial proliferation of donor CD4+ T cells followed by CD8+ T cells in secondary lymphoid organs with subsequent homing to the intestines, liver, and skin. Transplantation of purified naive T cells caused GVHD that was initiated in secondary lymphoid organs followed by target organ manifestation in gut, liver, and skin. In contrast, transplanted CD4+ effector memory T (TEM) cells did not proliferate in secondary lymphoid organs in vivo and despite their in vitro alloreactivity in mixed leukocyte reaction (MLR) assays did not cause acute GVHD. These findings underline the potential of T-cell subsets with defined trafficking patterns for immune reconstitution without the risk of GVHD.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
GVHD: in vivo veritas
- James L. M. Ferrara
Blood 2005 106: 772-773.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
E. Gatza, C. E. Rogers, S. G. Clouthier, K. P. Lowler, I. Tawara, C. Liu, P. Reddy, and J. L. M. Ferrara
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells
Blood,
August 15, 2008;
112(4):
1515 - 1521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Togel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Am J Physiol Renal Physiol,
July 1, 2008;
295(1):
F315 - F321.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Anderson, P. A. Taylor, J. M. McNiff, D. Jain, A. J. Demetris, A. Panoskaltsis-Mortari, A. Ager, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik
Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells
Blood,
May 15, 2008;
111(10):
5242 - 5251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. K. Jasperson, C. Bucher, A. Panoskaltsis-Mortari, P. A. Taylor, A. L. Mellor, D. H. Munn, and B. R. Blazar
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
Blood,
March 15, 2008;
111(6):
3257 - 3265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Beilhack, S. Schulz, J. Baker, G. F. Beilhack, R. Nishimura, E. M. Baker, G. Landan, E. I. Herman, E. C. Butcher, C. H. Contag, et al.
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs
Blood,
March 1, 2008;
111(5):
2919 - 2928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stelljes, S. Hermann, J. Albring, G. Kohler, M. Loffler, C. Franzius, C. Poremba, V. Schlosser, S. Volkmann, C. Opitz, et al.
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography
Blood,
March 1, 2008;
111(5):
2909 - 2918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Kim, T. H. Terwey, J. L. Zakrzewski, D. Suh, A. A. Kochman, M. E. Chen, C. G. King, C. Borsotti, J. Grubin, O. M. Smith, et al.
Organ-derived dendritic cells have differential effects on alloreactive T cells
Blood,
March 1, 2008;
111(5):
2929 - 2940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Zheng, C. Matte-Martone, H. Li, B. E. Anderson, S. Venketesan, H. Sheng Tan, D. Jain, J. McNiff, and W. D. Shlomchik
Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease
Blood,
February 15, 2008;
111(4):
2476 - 2484.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zeiser, D. B. Leveson-Gower, E. A. Zambricki, N. Kambham, A. Beilhack, J. Loh, J.-Z. Hou, and R. S. Negrin
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Blood,
January 1, 2008;
111(1):
453 - 462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Doubrovin, E. S. Doubrovina, P. Zanzonico, M. Sadelain, S. M. Larson, and R. J. O'Reilly
In vivo Imaging and Quantitation of Adoptively Transferred Human Antigen-Specific T Cells Transduced to Express a Human Norepinephrine Transporter Gene
Cancer Res.,
December 15, 2007;
67(24):
11959 - 11969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zeiser, S. Youssef, J. Baker, N. Kambham, L. Steinman, and R. S. Negrin
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Blood,
December 15, 2007;
110(13):
4588 - 4598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dutt, D. Tseng, J. Ermann, T. I. George, Y. P. Liu, C. R. Davis, C. G. Fathman, and S. Strober
Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease
J. Immunol.,
November 15, 2007;
179(10):
6547 - 6554.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chakraverty and M. Sykes
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
Blood,
July 1, 2007;
110(1):
9 - 17.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-K. Kim, A. Karasov, and J. C. Boothroyd
Bradyzoite-Specific Surface Antigen SRS9 Plays a Role in Maintaining Toxoplasma gondii Persistence in the Brain and in Host Control of Parasite Replication in the Intestine
Infect. Immun.,
April 1, 2007;
75(4):
1626 - 1634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Chen, D. Deoliveira, X. Cui, N. T. Le, J. Son, J. F. Whitesides, and N. J. Chao
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
Blood,
April 1, 2007;
109(7):
3115 - 3123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. H. Nguyen, R. Zeiser, D. L. daSilva, D. S. Chang, A. Beilhack, C. H. Contag, and R. S. Negrin
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Blood,
March 15, 2007;
109(6):
2649 - 2656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Blood,
March 1, 2007;
109(5):
2225 - 2233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Zhang, J. Lou, N. Li, I. Todorov, C.-L. Lin, Y.-A. Cao, C. H. Contag, F. Kandeel, S. Forman, and D. Zeng
Donor CD8+ T Cells Mediate Graft-versus-Leukemia Activity without Clinical Signs of Graft-versus-Host Disease in Recipients Conditioned with Anti-CD3 Monoclonal Antibody
J. Immunol.,
January 15, 2007;
178(2):
838 - 850.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Chakraverty, D. Cote, J. Buchli, P. Cotter, R. Hsu, G. Zhao, T. Sachs, C. M. Pitsillides, R. Bronson, T. Means, et al.
An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues
J. Exp. Med.,
August 7, 2006;
203(8):
2021 - 2031.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zeiser, V. H. Nguyen, A. Beilhack, M. Buess, S. Schulz, J. Baker, C. H. Contag, and R. S. Negrin
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Blood,
July 1, 2006;
108(1):
390 - 399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Becker, R. D. Wright, R. Satchi-Fainaro, T. Funakoshi, J. Folkman, A. L. Kung, and R. J. D'Amato
A Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy
Am. J. Pathol.,
June 1, 2006;
168(6):
2074 - 2084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Chan, C. A. Hamilton, M. K. Cheung, M. Karimi, J. Baker, J. M. Gall, S. Schulz, S. H. Thorne, N. N. Teng, C. H. Contag, et al.
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.
Clin. Cancer Res.,
March 15, 2006;
12(6):
1859 - 1867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. F. M. Vasconcelos, B. M. dos Santos, J. Farache, T. S. S. Palmeira, R. B. Areal, J. M. T. Cunha, M. A. Barcinski, and A. Bonomo
G-CSF-treated granulocytes inhibit acute graft-versus-host disease
Blood,
March 1, 2006;
107(5):
2192 - 2199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Anderson, W. D. Shlomchik, and M. J. Shlomchik
The Influence of Migration, Alloreactive Repertoire and Memory Subset on the Differential Ability of Naive and Memory T Cells To Induce GVHD.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
577 - 577.
[Abstract]
|
|
|
|
|
|
|
C. H. Schimmelpfennig, S. Schulz, C. Arber, J. Baker, I. Tarner, J. McBride, C. H. Contag, and R. S. Negrin
Ex Vivo Expanded Dendritic Cells Home to T-Cell Zones of Lymphoid Organs and Survive in Vivo after Allogeneic Bone Marrow Transplantation
Am. J. Pathol.,
November 1, 2005;
167(5):
1321 - 1331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
